The Board of Directors of Krishna Institute of Medical Sciences Limited convened a meeting on May 15, 2026, commencing at 2:00 PM and concluding at 5:00 PM, during which it approved a series of key organizational appointments and a board-level re-designation. The disclosures were made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Appointment of Cost Auditors

The board approved the appointment of M/s. Sagar & Associates, Cost Accountants, as the Cost Auditors of the company for the financial year 2026-27. The firm has been engaged to conduct the audit of the cost records of the company for the term April 1, 2026 to March 31, 2027, with the appointment effective May 15, 2026.

M/s. Sagar & Associates is described as a leading firm of Cost & Management Accountants with diversified activities in the Cost and Management Accounting area. The firm comprises qualified Cost Accountants and has undertaken assignments across various industries, serving leading companies with multiple locations and diversified product portfolios. The firm also has significant exposure to ERP systems, including SAP and ORACLE.

Senior Management Personnel Appointments

Based on the recommendation of the Nomination and Remuneration Committee at its meeting held on May 15, 2026, the board identified the following officials as Senior Management Personnel of the company with immediate effect:

Profiles of Newly Appointed Senior Management Personnel

Mr. Sachin Ashok Salvi – Chief Finance Officer

Mr. Salvi is a Chartered Accountant with over 21 years of experience in finance, accounting, financial reporting, and regulatory compliance. He has played a key role in managing IPO processes, including financial restatements and due diligence. His expertise spans IndAS, ICDS, ICDR regulations, GST, direct and indirect taxation, and regulatory liaison with SEBI, RBI, and tax authorities. He began his career with SD Khanolkar & Co., Mumbai, and later served as Finance Controller and CFO at Thyrocare Group, Navi Mumbai.

Mrs. Nagajayanthi J.R – Company Secretary & Compliance Officer

Mrs. Nagajayanthi J.R is a Fellow Member of the Institute of Company Secretaries of India. She holds a B.A. (Honours) in Economics from Delhi University, a Law degree from Osmania University, and has completed both a Master's degree and a Doctorate in Financial Management. She brings over 25 years of experience in the fields of Secretarial practice, Legal affairs, Corporate Finance, and Compliance.

Mr. Bhaskar Reddy R.K – Chief Risk Officer & Chief Internal Audit

Mr. Bhaskar Reddy R.K is a Chartered Accountant with over 12 years of experience in managing internal audits, governance reviews, risk assessments, and control evaluations. He is skilled in identifying process inefficiencies, strengthening internal controls, improving governance frameworks, and delivering actionable recommendations to management for operational and risk optimization. His experience includes 3 years with global consulting firms — Deloitte and BDO — in Risk Advisory and Business Restructuring engagements.

Re-designation of Mr. Adwik Bollineni

The board also approved the re-designation of Mr. Adwik Bollineni from Non-Executive & Non-Independent Director to Executive & Non-Independent Director of the company, effective May 15, 2026. Mr. Bollineni is a governing member of the Aditya Educational Society and has transformed Srikakulam's Great Eastern Medical School (GEMS) into Andhra Pradesh's second most sought-after medical college. Under his leadership, GEMS became the first and only Indian institution accredited by the Royal College of Surgeons of England for surgical excellence, and GEMS earned the 2024 Chief Minister's Award as the best hospital in Andhra Pradesh. Mr. Adwik Bollineni is the son of Dr. B. Bhaskara Rao, CMD, and brother of Dr. Abhinay Bollineni, Director & CEO.

Regulatory Disclosure

All disclosures pertaining to these appointments and re-designation have been made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated 30th January 2026. The relevant information has also been uploaded on the company's website at kimshospitals.com under the Disclosures section.

Krishna Institute of Medical Sciences Limited (KIMS Hospitals) has entered into a long-term lease agreement for 2 acres of land in Amaravati, Andhra Pradesh, for a period of 60 years. The agreement has been executed with the Andhra Pradesh Capital Region Development Authority (APCRDA) and was disclosed to stock exchanges on 8th May, 2026, as a material event.

Key Details of the Lease Agreement

The following table outlines the key parameters of the lease agreement as disclosed by the company:

Proposed Hospital and Specialties

The proposed facility is described as a state-of-the-art 500-bedded multi-speciality hospital that will offer comprehensive tertiary and quaternary care. The hospital is planned to cover a wide range of medical specialties, as detailed below:

• Cardiology
• Oncology
• Neurosciences
• Gastroenterology
• Orthopaedics
• Mother & Child Care
• Critical Care
• Organ Transplant
• Other key specialties

Healthcare Access in the Region

According to the company's disclosure, the proposed hospital aims to address a long-standing need for advanced healthcare infrastructure in the Amaravati region. The facility is expected to provide patients in Amaravati and surrounding districts of Andhra Pradesh with access to high-end clinical capabilities, reducing the need to travel to other metros for specialized medical care.

The disclosure was signed by Nagajayanthi J. R., Company Secretary and Compliance Officer of Krishna Institute of Medical Sciences Limited, and was submitted to both BSE and NSE on 8th May, 2026.